WHIPPANY, N.J., June 24, 2015 /PRNewswire/ -- Pazoo, Inc.
(OTC Pinks: PZOO) (German WKN#: A1J3DK), is pleased to report that
on Wednesday, June 3, 2015,
Pazoo acquired the remaining 60% of MA & Associates, LLC
in exchange for 900,000 shares of Pazoo's Series C. Preferred
stock. This now makes MA & Associates, LLC a 100% wholly-owned
subsidiary of Pazoo.
Pazoo is now comprised of three wholly-owned subsidiaries: MA
& Associates, LLC, Harris Lee,
LLC, and CannabisKing Distribution, LLC. 100% of the revenue
generated by each subsidiary will now be consolidated and recorded
on Pazoo's financial statements moving forward. Management
teams from both MA and Pazoo collaboratively felt this move was in
the best interests of all parties involved to maximize the inherent
value for the overall company.
MA & Associates CEO, Antonio Del
Hierro, commented, "The MA Management team felt that it was
the perfect moment to have MA & Associates completely join the
Pazoo Family of companies. We all have the same goal to create the
greatest amount of fundamental value across the board. The
Grand Opening could not have gone better. We will settle for
nothing less than to be the standard for Marijuana testing."
ABOUT PAZOO Inc.
Pazoo, Inc., is a company focused on health, wellness and
safety. Our focus is to provide best-in-class laboratory testing of
cannabis and cannabinoids to protect consumers from impurities,
contaminants and other irregularities. Through our wholly-owned
subsidiary, Harris Lee, and our
partnership with MA & Associates, Pazoo provides
industry-leading laboratory testing of cannabis. Harris Lee's and MA's license agreements with
Steep Hill Labs, Inc. allows the Pazoo subsidiaries to use Steep
Hill's top-rated testing protocols in select markets as we expand
throughout the USA. Pazoo's
subsidiaries are currently licensed to test cannabis in
Nevada, Oregon and Colorado, with other states to come.
Additionally, Pazoo delivers a comprehensive array of health and
wellness information on its website www.pazoo.com.
ABOUT STEEP HILL LABS Inc.
Founded in California in 2008,
Steep Hill is a science and technology firm that has become
the industry leader in cannabis testing and analytics. With owned
and licensed labs in four U.S. states and plans to add labs in
New Mexico, Oregon and possibly Jamaica in 2015, Steep Hill is the largest
cannabis lab network in the world. The company pioneered the first
medical cannabis potency and microbiological contaminants testing
methodology for use in California
- the first state to legalize medical cannabis. Steep Hill
has since developed a variety of revolutionary cannabis testing
products, including QuantaCann™,
QuantaCann2™ and GenKit™. Steep
Hill provides expert consulting services to many states,
countries and municipalities, and the company is developing
proprietary genetic testing, mapping and trademark protection
services for the industry as well.
Safe Harbor Statement:
This update includes forward-looking statements. These
forward-looking statements generally can be identified by phrases
such as Pazoo, Inc. or its management "believes," "expects,"
"anticipates," "foresees," "forecasts," "estimates" or other words
or phrases of similar import. Similarly, statements herein that
describe the Company's business strategy, outlook, objectives,
plans, intentions or goals also are forward-looking statements. All
such forward-looking statements are subject to certain risks and
uncertainties that could cause actual results to differ materially
from those in forward-looking statement.
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/nevada-based-marijuana-testing-lab-company-ma--associates-llc-becomes-a-100-wholly-owned-subsidiary-of-pazoo-300103885.html
SOURCE Pazoo, Inc.